すべての画像(1)

資料

A1606

4-アセトアミドアンチピリン

Name: 4-アセトアミドアンチピリン
Brand: ALDRICH

97%

別名:

4-Acetylaminophenazone, N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)acetamide, N-Antipyrinylacetamide, NSC 331807

ログイン組織・契約価格を表示する

すべての画像(1)

About This Item

実験式（ヒル表記法）:

C₁₃H₁₅N₃O₂

CAS番号:

83-15-8

分子量:

245.28

Beilstein:

234585

EC Number:

201-457-0

MDL番号:

MFCD00003141

UNSPSCコード:

12352100

PubChem Substance ID:

24890565

アッセイ

97%

mp

200-203 °C (lit.)

SMILES記法

CN1N(C(=O)C(NC(C)=O)=C1C)c2ccccc2

InChI

1S/C13H15N3O2/c1-9-12(14-10(2)17)13(18)16(15(9)3)11-7-5-4-6-8-11/h4-8H,1-3H3,(H,14,17)

InChI Key

OIAGWXKSCXPNNZ-UHFFFAOYSA-N

類似した製品をお探しですか？訪問製品比較ガイド

保管分類コード

11 - Combustible Solids

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable

個人用保護具 (PPE)

Eyeshields, Gloves, type N95 (US)

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA）を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Further metabolism of 4-acetylaminoantipyrine, the major metabolite of aminopyrine, in rats.

T Tanaka et al.

Chemical & pharmaceutical bulletin, 35(8), 3519-3522 (1987-08-01)

Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva.

E Neddermann et al.

European journal of drug metabolism and pharmacokinetics, 13(2), 105-111 (1988-04-01)

Metabolites of dipyrone have been determined in the saliva of 18 volunteers following the oral intake of 0.5 g, 1.0 g, 1.5 g, 2.0 g and 2.5 g dipyrone. High concentrations were measured for N-methyl-aminoantipyrine (MAA), the other analgetic active

Inhibition of cyclooxygenases by dipyrone.

S C Pierre et al.

British journal of pharmacology, 151(4), 494-503 (2007-04-17)

Dipyrone is a potent analgesic drug that has been demonstrated to inhibit cyclooxygenase (COX). In contrast to classical COX-inhibitors, such as aspirin-like drugs, dipyrone has no anti-inflammatory effect and a low gastrointestinal toxicity, indicating a different mode of action. Here

The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction.

G Heinemeyer et al.

European journal of clinical pharmacology, 45(5), 445-450 (1993-01-01)

We have studied the clearance of monomethylaminoantipyrine (MMAAP), the pharmacologically active form of metamizol, in 46 patients in surgical intensive care with different degrees of renal dysfunction. In 23 patients without any renal impairment, mean clearance was 2.8 ml.min-1 x

Plasma protein binding of dipyrone metabolites in man.

E Zylber-Katz et al.

European journal of clinical pharmacology, 29(1), 67-71 (1985-01-01)

Four metabolites of dipyrone, 4-methylaminoantipyrine (MAA), 4-aminoantipyrine (AA), 4-formylaminoantipyrine (FAA) and 4-acetylaminoantipyrine (AAA) can be identified in human plasma after its oral administration. The plasma protein binding of the metabolites in samples from 20 healthy volunteers was determined by ultrafiltration.

資料